127 related articles for article (PubMed ID: 20807727)
21. A study of the relative importance of the peroxiredoxin-, catalase-, and glutathione-dependent systems in neural peroxide metabolism.
Mitozo PA; de Souza LF; Loch-Neckel G; Flesch S; Maris AF; Figueiredo CP; Dos Santos AR; Farina M; Dafre AL
Free Radic Biol Med; 2011 Jul; 51(1):69-77. PubMed ID: 21440059
[TBL] [Abstract][Full Text] [Related]
22. Peroxiredoxin I deficiency increases pancreatic β‑cell apoptosis after streptozotocin stimulation via the AKT/GSK3β signaling pathway.
Jin MH; Shen GN; Jin YH; Sun HN; Zhen X; Zhang YQ; Lee DS; Cui YD; Yu LY; Kim JS; Kwon T; Han YH
Mol Med Rep; 2020 Sep; 22(3):1831-1838. PubMed ID: 32705184
[TBL] [Abstract][Full Text] [Related]
23. Peroxiredoxin 1 plays a primary role in protecting pancreatic β-cells from hydrogen peroxide and peroxynitrite.
Stancill JS; Happ JT; Broniowska KA; Hogg N; Corbett JA
Am J Physiol Regul Integr Comp Physiol; 2020 May; 318(5):R1004-R1013. PubMed ID: 32292063
[TBL] [Abstract][Full Text] [Related]
24. Protective functions of peroxiredoxin-1 against cytokine-induced MIN6 pancreatic β-cell line death.
Lee YJ; Song DS; Yoo JS; Hyung KE; Lee MJ; Moon YH; Lee IH; Go BS; Park SY; Hwang KW
Can J Physiol Pharmacol; 2013 Dec; 91(12):1037-43. PubMed ID: 24289074
[TBL] [Abstract][Full Text] [Related]
25. APPL1 prevents pancreatic beta cell death and inflammation by dampening NFκB activation in a mouse model of type 1 diabetes.
Jiang X; Zhou Y; Wu KK; Chen Z; Xu A; Cheng KK
Diabetologia; 2017 Mar; 60(3):464-474. PubMed ID: 28011992
[TBL] [Abstract][Full Text] [Related]
26. DJ-1 Protects Pancreatic Beta Cells from Cytokine- and Streptozotocin-Mediated Cell Death.
Jain D; Weber G; Eberhard D; Mehana AE; Eglinger J; Welters A; Bartosinska B; Jeruschke K; Weiss J; Päth G; Ariga H; Seufert J; Lammert E
PLoS One; 2015; 10(9):e0138535. PubMed ID: 26422139
[TBL] [Abstract][Full Text] [Related]
27. Protection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis.
Zhao W; Fan GC; Zhang ZG; Bandyopadhyay A; Zhou X; Kranias EG
Basic Res Cardiol; 2009 Jul; 104(4):377-89. PubMed ID: 19030911
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic β-cells detoxify H
Stancill JS; Broniowska KA; Oleson BJ; Naatz A; Corbett JA
J Biol Chem; 2019 Mar; 294(13):4843-4853. PubMed ID: 30659092
[TBL] [Abstract][Full Text] [Related]
29. FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts.
Chiribau CB; Cheng L; Cucoranu IC; Yu YS; Clempus RE; Sorescu D
J Biol Chem; 2008 Mar; 283(13):8211-7. PubMed ID: 18195003
[TBL] [Abstract][Full Text] [Related]
30. Induction of the intrinsic apoptosis pathway in insulin-secreting cells is dependent on oxidative damage of mitochondria but independent of caspase-12 activation.
Mehmeti I; Gurgul-Convey E; Lenzen S; Lortz S
Biochim Biophys Acta; 2011 Oct; 1813(10):1827-35. PubMed ID: 21784110
[TBL] [Abstract][Full Text] [Related]
31. Induction of sulfiredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia.
Bae SH; Woo HA; Sung SH; Lee HE; Lee SK; Kil IS; Rhee SG
Antioxid Redox Signal; 2009 May; 11(5):937-48. PubMed ID: 19086807
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of peroxiredoxin 4 protects against high-dose streptozotocin-induced diabetes by suppressing oxidative stress and cytokines in transgenic mice.
Ding Y; Yamada S; Wang KY; Shimajiri S; Guo X; Tanimoto A; Murata Y; Kitajima S; Watanabe T; Izumi H; Kohno K; Sasaguri Y
Antioxid Redox Signal; 2010 Nov; 13(10):1477-90. PubMed ID: 20446767
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity profile of the human EndoC-βH1 beta cell line to proinflammatory cytokines.
Gurgul-Convey E; Mehmeti I; Plötz T; Jörns A; Lenzen S
Diabetologia; 2016 Oct; 59(10):2125-33. PubMed ID: 27460666
[TBL] [Abstract][Full Text] [Related]
34. Loss of Peroxiredoxin Expression Is Associated with an Aggressive Phenotype in Pancreatic Adenocarcinoma.
Isohookana J; Haapasaari KM; Soini Y; Karihtala P
Anticancer Res; 2016 Jan; 36(1):427-33. PubMed ID: 26722077
[TBL] [Abstract][Full Text] [Related]
35. The Role of Thioredoxin/Peroxiredoxin in the β-Cell Defense Against Oxidative Damage.
Stancill JS; Corbett JA
Front Endocrinol (Lausanne); 2021; 12():718235. PubMed ID: 34557160
[TBL] [Abstract][Full Text] [Related]
36. Investigation of peroxiredoxin IV as a calpain-regulated pathway in cancer.
Roumes H; Pires-Alves A; Gonthier-Maurin L; Dargelos E; Cottin P
Anticancer Res; 2010 Dec; 30(12):5085-9. PubMed ID: 21187494
[TBL] [Abstract][Full Text] [Related]
37. Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2).
Smith-Pearson PS; Kooshki M; Spitz DR; Poole LB; Zhao W; Robbins ME
Free Radic Biol Med; 2008 Oct; 45(8):1178-89. PubMed ID: 18718523
[TBL] [Abstract][Full Text] [Related]
38. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria.
Chang TS; Cho CS; Park S; Yu S; Kang SW; Rhee SG
J Biol Chem; 2004 Oct; 279(40):41975-84. PubMed ID: 15280382
[TBL] [Abstract][Full Text] [Related]
39. A redox-sensitive peroxiredoxin that is important for longevity has tissue- and stress-specific roles in stress resistance.
Oláhová M; Taylor SR; Khazaipoul S; Wang J; Morgan BA; Matsumoto K; Blackwell TK; Veal EA
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19839-44. PubMed ID: 19064914
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis.
Nonn L; Berggren M; Powis G
Mol Cancer Res; 2003 Jul; 1(9):682-9. PubMed ID: 12861054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
